Generic Name and Formulations:
Levofloxacin (as hemihydrate) 0.5%; oph. soln; contains benzalkonium chloride.
Vistakon Pharmaceuticals, LLC
Indications for QUIXIN:
Susceptible bacterial conjunctivitis.
Adults and Children:
<1yr: not recommended. ≥1yr: 1–2 drops in affected eye(s) every 2 hours while awake (max 8 times/day) on days 1 and 2, then 1–2 drops every 4 hours while awake (max 4 times/day) on days 3–7.
Discontinue if superinfection or hypersensitivity occurs. Pregnancy (Cat.C). Nursing mothers.
May potentiate theophylline, caffeine, oral anticoagulants. May cause elevated serum creatinine with cyclosporine.
Transient decreased vision, ocular burning, pain or discomfort, fever, foreign body sensation, headache, pharyngitis, photophobia.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Erdafitinib Granted FDA Breakthrough Therapy Designation for Urothelial Carcinoma
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- Nivolumab Plus Ipilimumab Improves Overall Survival, ORR in Renal Cell Carcinoma
- Encorafenib, Binimetinib May Be Effective in BRAF-Mutant Melanoma
- CLL: Venetoclax Plus Rituximab Improves 2-Year PFS
- Confronting Racial Disparities in Prostate Cancer Survival Outcomes
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma